Media OutReach
Johnson & Johnson and Asia Pacific Patient Advocacy Group Leaders Unite to Strengthen Shared Decision-Making in Lung Cancer Care
J&J deepens its commitment to patient empowerment in Asia Pacific by launching J&J withMe, a new patient portal offering tailored patient resources, and co-driving market-specific initiatives with patient advocacy groups
SINGAPORE – Media OutReach Newswire – 11 December 2025 – Johnson & Johnson announced the next phase of The 3rd Opinion campaign across Asia Pacific, focused on championing shared decision-making between lung cancer patients and healthcare professionals through events and stakeholder engagements at ESMO Asia 2025 in Singapore.
At a Patient Reception on 6th December 2025, 20 leaders from 17 patient advocacy groups from across Asia Pacific, Europe and the United States shared their support for the need to strengthen shared decision-making. On December 7, 2025, the ESMO Asia 2025 Symposium, ‘Advancing EGFRm NSCLC Treatment Through Shared Decision-Making’ highlighted the role of healthcare professionals not only in making sense of the data but also in helping patients and their families navigate complex decision-making.
“High prevalence in Asia of certain NSCLC mutations makes the choice of first-line therapy absolutely critical. Treatment decisions must balance clinical objectives with patient values — weighing disease biology, survival prospects, durable disease control and the tradeoffs of side effects. That’s why shared decision-making is essential: clinicians should present all appropriate treatment options, so the final choice is collaborative and aligned with each patient’s goals,” said Professor Zhu Zhengfei, Director of the Radiation Oncology Department, Fudan University Shanghai Cancer Center.
“When lung cancer patients are empowered to speak up and understand their options, they are more likely to continue the treatment and their dignity is preserved. Initiatives like ‘The 3rd Opinion’ are vital for fostering truly patient-centered partnerships between people living with cancer and their healthcare teams,” noted Ms. Liu Yiting, Marketing & Branding Director, China MeetHealth Mi-Jian Patient Community.
“The shared commitment validates what many people living with lung cancer have long expressed: shared decision making is essential. From our experience supporting patients, meaningful conversations with clinicians help acknowledge patients’ experiences, address their concerns, and preserving their hopes,” added Mr. Jung-Il Cho, Chairman of Korea Lung Cancer Patients Association.
Our commitment comes off the back of a recent patient survey revealing that 90% of Japanese lung cancer patients want to play an active role in their treatment decisions. The survey also found that shared decision-making, where physicians and patients jointly compare treatment options and decide together, is the strongest driver of treatment satisfaction.1
Patient survey finds that those engaged in shared decision-making were 11 times more likely to report higher satisfaction with their treatments, with 90% of lung cancer patients in Japan wanting to play an active role in their treatment decisions. This finding underscores the importance of shared decision-making and patient-centered care.1
To bridge the gap between patients’ desire to engage in shared decision making and their lack of practical support, J&J has launched “J&J withMe”, an online hub that equips lung cancer patients and caregivers with tailored toolkits and conversation guides to prepare for consultations and make informed, personalized treatment decisions.
Anthony Elgamal, Vice President of Oncology, Johnson & Johnson Innovative Medicine Asia Pacific said, “The 3rd Opinion truly puts patients at the center of care. As part of our deep commitment to address patients’ unmet needs, we will continue partnering with patient advocacy groups and healthcare professionals to help patients to find their voice and the moment when medical advice meets what truly matters to patients.”
In recognition of diverse cultural and clinical norms across Asia Pacific, J&J has also rolled out tailored market activations in collaboration with local patient advocacy groups:
- Provision of patient resources such as the “Lung Cancer Book of Answers” in China, ‘Value of Time’ video for patients in Japan, and educational assets in India and Australia/New Zealand;
- Digital and social media engagement featuring patients and creators discussing the importance of shared decision-making across Singapore, Malaysia, Philippines, Thailand, and Vietnam;
- Event engagement via the establishment of a patient advisory board in India;
- Corporate Social Responsibility program with a lung cancer patient group in Korea, bringing employees and patients together to better understand the disease burden of patients and strengthen emotional support for the patient community.
###
About the 3rd Opinion
“The 3rd Opinion”, the patient’s own opinion, is a new term that sparks a social movement in the lung cancer treatment journey – designed to elevate the patient voice and empower individuals to take an active role in shaping their treatment plan. By prioritizing shared decision-making between patients and healthcare professionals, this collaborative approach ensures that treatment choices are aligned to each patient’s goals, preferences and circumstances. This results in more informed decisions, greater patient satisfaction, and the best possible outcomes.
About Non-Small Cell Lung Cancer
Worldwide, lung cancer is one of the most common cancers, with NSCLC making up 80 to 85 percent of all lung cancer cases.[1], [2] The main subtypes of NSCLC are adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.[3] Among the most common driver mutations in NSCLC are alterations in EGFR, which is a receptor tyrosine kinase controlling cell growth and division.[4] EGFR mutations are present in 10 to 15 percent of Western patients with NSCLC with adenocarcinoma histology and occur in 40 to 50 percent of Asian patients.[5], [6],[7],[8],[9],[10] EGFR ex19del or EGFR L858R mutations are the most common EGFR mutations.[11] The five-year survival rate for all people with advanced NSCLC and EGFR mutations treated with EGFR tyrosine kinase inhibitors (TKIs) is less than 20 percent.[12],[13] EGFR exon 20 insertion mutations are the third most prevalent activating EGFR mutation.[14] Patients with EGFR exon 20 insertion mutations have a real-world five-year overall survival (OS) of eight percent in the frontline setting, which is worse than patients with EGFR ex19del or L858R mutations, who have a real-world five-year OS of 19 percent.[15]By comparison, other common cancers, such as breast and prostate cancer have a 5-year real world OS of 90% and 97% respectively[16].
[2] The World Health Organization. Cancer. https://www.who.int/news-room/fact-sheets/detail/cancer. Accessed March 2025.
Hashtag: #Johnson&Johnson
The issuer is solely responsible for the content of this announcement.
About Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.
Learn more at 
https://www.jnj.com/ or at www.innovativemedicine.jnj.com. Follow us at @JNJInnovMed.
Johnson & Johnson Innovative Medicine Asia Pacific, a division of Johnson & Johnson International (Singapore) Pte. Ltd is a Johnson & Johnson company.
© Johnson & Johnson International (Singapore) Pte. Ltd. [2025] All rights reserved.
Media OutReach
No Judgement, No Awkwardness: More Hongkongers Are Opening Up to AI for Mental Health Support
A newly completed Hong Kong study suggests there may finally be a way to bridge that gap. The AIM Greater China Psychology Research Group has completed a Hong Kong-based study conducted in the 2025–2026 academic year, comparing the effectiveness of human hypnotherapists against AI in delivering hypnotic experience-based stress relief experiences. The findings were striking: a significant proportion of participants felt that both approaches yielded virtually equivalent levels of relaxation — and more than 60% reported preferring their AI session after the fact.
Over 400 Applicants: A Reflection of a Generation in Need of Being Heard
The research team recruited participants experiencing family-related stress via Facebook. Within a short period of the post going live, over 400 individuals voluntarily applied — a figure that speaks not only to the pervasiveness of stress in modern life, but also to a growing willingness among the public to prioritise their own emotional wellbeing and actively seek self-care solutions.
From the applicant pool, 48 participants were randomly selected to take part. Each participant underwent two separate hypnotic experience stress relief audio sessions, each lasting approximately one hour — one recorded by a human hypnotherapist, and one fully generated by AI, including both the script and voice. Participants then compared their personal experiences of both sessions.
What Humans Can Do, AI Can Do Too
In the most critical area of comparison — stress relief effectiveness — the largest single group of participants (41.7%) rated the AI and human sessions as equally effective. On a scoring basis, the AI hypnotic experience averaged approximately 2.92 points, compared to 2.58 points for the human session — with AI coming out marginally ahead.
The study further found that nearly 90% of participants indicated they would enjoy a session if it genuinely helped them feel relaxed. In other words, what people truly care about is whether it works — not whether the voice behind it belongs to a human or a machine. On this front, AI has passed the test.
Over 60% More Willing to Share Their Feelings with AI
The results around personal preference were perhaps the most eye-opening. When asked which session they enjoyed more, 62.5% of participants chose the AI experience — and among women, that number climbed even higher, to 68.4%.
So what made AI the preferred choice? Researchers believe it comes down to one simple thing: feeling safe. With AI, there is no worry about being judged. No fear of saying the wrong thing. No awkwardness. About 1 in 4 participants said they actually found it easier to talk openly with AI — because it communicates in a way that feels clear, calm, and natural, much like everyday conversation.
The truth is, some things are just easier to say when no one is watching. That is not a flaw in human nature — it is simply how many of us work.
When it came to privacy, the findings were equally reassuring. More than half of all participants said they had no concerns about AI handling their personal information. Only a very small number — just 2.08% — said they felt uncomfortable. This points to a growing sense of trust in AI tools among the general public.
AI Reads the Data; Therapists Read the Person
Beyond the hypnotic experience itself, the local research team also evaluated AI’s capability as an analytical tool — with equally impressive results.
AI was able to rapidly process large volumes of participant responses, objectively assess individual stress levels, and identify underlying patterns. For instance, AI identified that 35% of participants independently expressed a desire for “personal space” or “better soundproofing” in their homes. On the surface, these may seem like trivial lifestyle concerns — yet AI connected this pattern to the reality of Hong Kong residents living in constrained spaces, highlighting a deeper psychological sense of having “nowhere to breathe”. This level of insight would be difficult to uncover through manual review of dozens of questionnaires alone.
AI also observed that many participants habitually occupied the role of “problem-solver” or “mediator” within their households, suppressing their own emotional needs in the process. Researchers noted that this reflects a widely recognised social phenomenon — the pressures faced by eldest daughters and the so-called “sandwich generation,” caught between the responsibilities of caring for ageing parents and raising children. AI’s ability to rapidly identify these hidden emotional burdens allows therapists to bypass lengthy preliminary assessments and focus more swiftly on the core issues that require their attention.
AI Is Here to Help, Not to Take Over
The local research team emphasises that the study was never intended to position AI as a replacement for human therapists. Rather, the aim is to explore how the two can work in tandem. Much like how blood test reports assist physicians in diagnosis, AI can play an analogous supporting role in the mental health field — organising data, identifying patterns, and lowering barriers to seeking help, so that mental health professionals can direct their energy towards the moments that truly require a human touch.
Those who proactively seek psychological support remain a minority, often deterred by the fear of inconvenience, social stigma, or the awkwardness of speaking up. If AI can serve as the bridge that encourages more people to take that first step, that alone may be its most meaningful contribution to society.
Hashtag: #HypnosisInstitute
The issuer is solely responsible for the content of this announcement.
About Hypnosis Institute
Hypnosis Institute is dedicated to helping people in Hong Kong lead healthier and more fulfilling lives through hypnotic experience. We offer accessible and practical hypnotic experience training programmes designed to integrate hypnotic techniques into everyday life, with a focus on stress management, emotional wellbeing, and personal growth.
Hypnosis Institute is Hong Kong’s only hypnotic experience professional development platform that simultaneously operates a research group, social innovation group, practical training group, crisis psychological support group, charitable initiatives, networking events, therapeutic services, and a comprehensive training pathway.
As the sole Hong Kong chapter of the Association for Integrative Medicine (AIM) in the United States, the sole overseas Hong Kong academy of UK educational institution Study House (Quality Licence Scheme), and the sole specialist hypnotic experience training school in Hong Kong under Cambridge International College in the United Kingdom, Hypnosis Institute provides internationally recognised qualifications that contribute to the advancement of the industry.
Founder Charles Leung is a trainer of trainers in the field of hypnotic experience, and has been specially appointed by the Association for Integrative Medicine as the Chief Instructor for Specialist hypnotic experience in Greater China. He has trained over 1,000 hypnotherapists and instructors, upholding the highest standards of professional development in the mental health field.
The Institute’s programmes integrate a comprehensive range of methodologies, including hypnotic experience combined with MBTI personality profiling, DISC behavioural analysis, mental health coaching, emotional education, and the HiddenMe Cards inner child tool — providing a holistic and personalised approach to hypnotic experience practice. Instructors specialise in paediatric hypnotic experience, Internal Family Systems (including inner child) hypnotic experience, stress and insomnia relief hypnotic experience, interpersonal relationship hypnotic experience, as well as hypnotic experience in reminiscence and palliative care.
Driven by the belief that everyone can harness the power of hypnotic experience to enhance their mental wellbeing, Hypnosis Institute is committed to sharing psychological knowledge and providing professional support in the areas of emotional management, life challenges, and the professional development of the hypnotic experience industry.
Follow us at hypnosisinstitute.com.hk, 
Facebook, 
Instagram and 
YouTube for the latest updates.
Held at deMori @ FCC Signature, the event featured a live platform demonstration, partner showcase, and networking sessions aimed at facilitating engagement between founders, advisors, and investors.
Introducing CapitalOS
CapitalOS, BizPal’s corporate finance platform, was presented through a live demonstration during the event. The system integrates operational, brand, and financial data into a structured framework designed to support investor readiness and due diligence.
According to BizPal, the platform is intended to help SMEs organise their business information into formats aligned with investor expectations, enabling clearer communication during fundraising discussions.
“SMEs should never walk into a funding conversation unsure of their numbers,” said Ms. Anya Tan, CEO of BizPal Malaysia.
MOUs Expand Distribution Network
The event also included the signing of Memoranda of Understanding between BizPal and two Malaysian partners, My Education Platform and VA Partners. Both organisations will serve as authorised distributors of BizPal’s education and advisory programmes across Malaysia.
The partnerships expand BizPal’s reach within the SME ecosystem by working with local organisations that support business development and capability building.
“Partnering with BizPal allows us to introduce structured, investor-ready methodologies to the SME community we serve,” said Mr. Jeff Lee, Director, My Education Platform.
A representative from VA Partners is expected to provide a statement following final endorsement.
Global Mentorship Exchange (GMX)
During the event, BizPal also presented the Global Mentorship Exchange (GMX), an ecosystem initiative designed to connect experienced business leaders with high-potential entrepreneurs.
The initiative provides a structured environment for mentorship supported by data-based evaluation and standardised assessment criteria aligned with investor expectations. GMX was first introduced during BizPal’s Data Fundraising Masterclass in December 2025 and was presented to a broader network of partners and investors at BizPal Day.
Next Steps
Following the event, BizPal plans to expand the adoption of CapitalOS and continue developing its partner network across Malaysia and the ASEAN region.
Hashtag: #NoDataNoTalk #DataFundraising #InvestorReady #CapitalReadiness #FinTech #BusinessValuation #ASEANSMEs #BizPalDay
https://www.bizpal.tech/
https://www.facebook.com/simplyfi.sg
The issuer is solely responsible for the content of this announcement.
About BizPal
BizPal provides data-driven corporate finance solutions designed to help ASEAN SMEs become investor-ready. Its platform, CapitalOS, integrates operational, strategic, and financial data into a unified system that supports business evaluation and investor engagement.
Media OutReach
Vinhomes Green Paradise Can Gio And IHG Hotels & Resorts Partner To Bring Four International Hotel Brands To The Coastal Mega Urban Development
Under the agreement, IHG will develop four hotels with a total of more than 1,000 rooms at Vinhomes Green Paradise Can Gio, including InterContinental Saigon Can Gio with 400 rooms, Crowne Plaza Saigon Can Gio with 400 rooms, Holiday Inn Express Saigon Can Gio with 130 rooms, and Garner Saigon Can Gio with 130 rooms.
InterContinental Saigon Can Gio, a world-renowned luxury brand, will deliver premium hospitality experiences tailored to international travelers and domestic guests seeking high-end accommodation. Crowne Plaza Saigon Can Gio, one of the largest upscale hotel brands globally, will cater to frequent travelers with modern, flexible spaces designed to optimize productivity and foster connections.
Holiday Inn Express Saigon Can Gio and Garner Saigon Can Gio will expand the destination’s accommodation offering with efficient, high-quality stays focused on value, making the development more accessible to a broader range of guests. This also marks the official debut of both brands in the Vietnamese market.
According to the development timeline, Holiday Inn Express Saigon Can Gio and Garner Saigon Can Gio are expected to open in 2028, followed by InterContinental Saigon Can Gio and Crowne Plaza Saigon Can Gio in 2030.
In this partnership, Vinpearl, a member of Vingroup, will act as the project operator and lead the collaboration with IHG Hotels & Resorts, while coordinating with all stakeholders throughout the development and operational phases.
Together with Vinpearl’s world-class hospitality brand, the addition of four premium IHG hotels will help realize a 7,000-room accommodation ecosystem at Vinhomes Green Paradise Can Gio, meeting the growing demand for extended stays and diverse experiences year-round in Can Gio and Ho Chi Minh City.
Complementing the hospitality offering, a series of large-scale entertainment and resort facilities unique to Vinhomes Green Paradise Can Gio will further elevate the destination. These include the 122-hectare VinWonders theme park featuring the world’s tallest artificial snow mountain and nearly 200 attractions, the 5,000-seat Blue Waves Theater, the 800-hectare Paradise Lagoon, the five-star international cruise port Landmark Harbour, and two 18-hole international-standard golf courses. Together, these developments aim to position Can Gio as a globally-recognized tourism and resort hub, targeting 40 million visitors annually and standing alongside leading destinations in Vietnam and worldwide.
Mr. Rajit Sukumaran, Senior Vice President and Managing Director, East Asia & Pacific, IHG Hotels & Resorts, said: “This agreement marks the beginning of a strategic partnership between IHG and Vingroup. Bringing four of our standout brands to Vinhomes Green Paradise Can Gio reflects the diversity of our portfolio, as well as our strong commitment to supporting Vietnam’s goal of becoming a leading global tourism destination. With brands spanning multiple segments, we believe this collaboration will help create an integrated hospitality ecosystem that meets the diverse needs of travelers at one of Vietnam’s most significant developments.”
Ms. Ngo Thi Huong, Chief Executive Officer of Vinpearl Joint Stock Company, said: “We selected IHG not only for its global brand portfolio but also for its proven operational expertise across international markets. Introducing InterContinental, Crowne Plaza, Holiday Inn Express, and Garner to Vinhomes Green Paradise Can Gio is a key step in completing our service structure and establishing international operating standards for the mega project’s hotel system. With this partnership as a foundation, we believe Vinhomes Green Paradise will progressively emerge as a world-class destination, where a fully integrated ecosystem continues to enhance its appeal to residents and both domestic and international visitors.”
Vinhomes Green Paradise is located in the southeastern part of Ho Chi Minh City. Construction began on April 19, 2025, with a total area of 2,870 hectares. The development features three sides facing the sea and is adjacent to the Can Gio Mangrove Biosphere Reserve, a UNESCO-recognized site. The project is being developed to leading ESG++ standards, integrating green, smart, ecological, and regenerative principles.
The development benefits from a well-connected transport infrastructure network, including the Ben Thanh – Can Gio high-speed railway, which will reduce travel time from central Ho Chi Minh City to just 13 minutes, the Can Gio Bridge, the interchange connecting Rung Sac Road with the Ben Luc – Long Thanh Expressway, and the Can Gio – Vung Tau sea-crossing route, enabling travel between two major tourism hubs in just 10 minutes.
With a diverse range of accommodation options, internationally-standardized hotel systems, and a wide array of cultural, artistic, sports, and entertainment facilities aligned with green, smart, and community-friendly principles, Vinhomes Green Paradise Can Gio stands out as a rare mega urban development that both sets new benchmarks for ESG living and delivers a world-class tourism and resort experience.
Hashtag: #Vinhomes
The issuer is solely responsible for the content of this announcement.
About IHG Hotels & Resorts:
IHG Hotels & Resorts is a global hospitality company with a portfolio of 21 brands and IHG One Rewards, one of the world’s largest hotel loyalty programs with over 160 million members. IHG currently franchises, leases, manages, or owns more than 6,900 hotels across over 100 countries, with more than 2,300 hotels in its development pipeline.
IHG’s brand portfolio spans Luxury & Lifestyle, Premium, Essentials, and Suites segments, including well-known brands such as Six Senses, Regent, InterContinental, Crowne Plaza, Holiday Inn Express, Garner, Staybridge Suites, and Candlewood Suites.
About Vinhomes
Vinhomes is Vietnam’s leading real estate developer, pioneering the development of large-scale, well-planned urban areas with integrated amenities, green living environments, and modern lifestyles. In addition to 36 urban developments currently in operation nationwide, Vinhomes continues to focus on building next-generation mega and super urban developments of regional scale and significance, aspiring to create some of the most livable cities in the world while significantly transforming Vietnam’s urban landscape.
For more information, please visit https://vinhomes.vn/vi
-
Feature/OPED6 years agoDavos was Different this year
-
Travel/Tourism10 years ago
Lagos Seals Western Lodge Hotel In Ikorodu
-
Showbiz3 years agoEstranged Lover Releases Videos of Empress Njamah Bathing
-
Banking8 years agoSort Codes of GTBank Branches in Nigeria
-
Economy3 years agoSubsidy Removal: CNG at N130 Per Litre Cheaper Than Petrol—IPMAN
-
Banking3 years agoSort Codes of UBA Branches in Nigeria
-
Banking3 years agoFirst Bank Announces Planned Downtime
-
Sports3 years agoHighest Paid Nigerian Footballer – How Much Do Nigerian Footballers Earn